Holen Sie sich die Stockscreener-App
3.08
6.95%
-0.23
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
Cellectar Advances CLR 125 Into Early Breast Cancer Trial, Adding Depth to Its Radiotherapy Pipeline - TipRanks
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference - Investing News Network
Cellectar Biosciences to highlight strategic initiatives for 2026 - MarketScreener
Cellectar Biosciences Outlines 2026 Strategic Plan and Regulatory Milestones for Iopofosine I 131 and CLR 125 at Biotech Showcase - Quiver Quantitative
Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase ... - Bluefield Daily Telegraph
Cancer-focused biotech maps 2026 push in blood and breast tumors - Stock Titan
HOKA Comfort Guide: Is Cellectar Biosciences Inc. stock dividend yield sustainableWide Width Options & support options for steady strides - ulpravda.ru
How Cellectar Biosciences Inc. stock performs in rate cut cyclesWeekly Profit Recap & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Sentiment Review: What catalysts could drive Cellectar Biosciences Inc stock higherPortfolio Profit Report & Low Risk Entry Point Guides - moha.gov.vn
ABTBiotech Stocks Forge Ahead With Confidence on This Week's Healthy Biotech Rally - ADVFN
What catalysts could drive Cellectar Biosciences Inc. stock higherJuly 2025 Catalysts & Weekly Breakout Watchlists - ulpravda.ru
Why retail investors favor Cellectar Biosciences Inc. stockStop Loss & Real-Time Buy Signal Notifications - ulpravda.ru
Momentum Shift: Will Cellectar Biosciences Inc. stock outperform value stocksMarket Performance Recap & Weekly High Conviction Trade Ideas - ulpravda.ru
Published on: 2026-01-09 06:04:32 - ulpravda.ru
Is Cellectar Biosciences Inc. stock ready for breakoutForecast Cut & High Yield Stock Recommendations - ulpravda.ru
Trend Report: What catalysts could drive Cellectar Biosciences Inc. stock higherWeekly Market Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
Bond Watch: Why retail investors favor Cellectar Biosciences Inc. stock2025 Volume Leaders & Weekly Momentum Stock Picks - ulpravda.ru
Is Cellectar Biosciences Inc. stock a buy before product launchesWeekly Loss Report & AI Forecast Swing Trade Picks - ulpravda.ru
Is Cellectar Biosciences Inc. stock attractive for retirement portfoliosJuly 2025 Sentiment & Proven Capital Preservation Methods - ulpravda.ru
Will Cellectar Biosciences Inc. stock beat EPS estimatesJuly 2025 Sector Moves & Community Verified Watchlist Alerts - ulpravda.ru
Why Cellectar Biosciences Inc. stock could rally in 2025Earnings Per Share Trends & Affordable Market Strategies - ulpravda.ru
Trade Report: Why Rezolve AI PLC stock appeals to dividend seekersWeekly Trading Summary & Fast Momentum Entry Tips - moha.gov.vn
What drives Cellectar Biosciences Inc stock priceHealthcare Stock Analysis & Affordable Growth Trading - earlytimes.in
Targets Report: Why retail investors favor Cellectar Biosciences Inc stockMarket Growth Review & Accurate Entry/Exit Alerts - moha.gov.vn
Layoff Watch: Will Cellectar Biosciences Inc stock outperform value stocksBond Market & Community Verified Trade Signals - moha.gov.vn
Can Ahimsa Industries Limited Regain Momentum After BreakdownMarket Rumors and News & Affordable Stock Market Tips - earlytimes.in
Will Cellectar Biosciences Inc. stock reach Wall Street targets2025 Investor Takeaways & Real-Time Volume Spike Alerts - Улправда
How Cellectar Biosciences Inc. (NV4) stock reacts to weak economyJuly 2025 WrapUp & Smart Allocation Stock Reports - Bölüm Sonu Canavarı
Will Cellectar Biosciences Inc. stock benefit from sector rotation2025 Stock Rankings & Low Volatility Stock Suggestions - Улправда
Why Cellectar Biosciences Inc. stock remains undervaluedJuly 2025 Weekly Recap & Long-Term Safe Investment Ideas - Улправда
Aug Swings: Will Cellectar Biosciences Inc. stock reach Wall Street targets2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
How Cellectar Biosciences Inc. stock trades before earningsJuly 2025 Volume & Low Risk Entry Point Tips - Улправда
Should I buy Cellectar Biosciences Inc. (NV4) stock before earnings seasonJuly 2025 Update & Real-Time Market Trend Scan - DonanımHaber
What MACD trends signal for Cellectar Biosciences Inc. (NV4) stock2025 Short Interest & Verified Momentum Stock Alerts - Улправда
Bond Watch: Why Cellectar Biosciences Inc. stock could rally in 2025July 2025 Setups & Momentum Based Trading Ideas - Улправда
Cellectar Biosciences announces supply agreement with Ionetix - MSN
Cellectar Biosciences, Inc. (CLRB) director John Neis reports stock sale - Stock Titan
Cellectar secures multi-year supply of alpha-emitting radioisotopes By Investing.com - Investing.com Australia
Cellectar Biosciences : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Cellectar Biosciences announces strategic supply agreement with Ionetix - marketscreener.com
Cellectar Biosciences (CLRB) Secures Supply Agreement for Radioi - GuruFocus
Cellectar secures multi-year supply of alpha-emitting radioisotopes - Investing.com
Cellectar Biosciences Announces Multi-Year Supply Agreement with Ionetix for Alpha-Emitting Radioisotopes - Quiver Quantitative
Cellectar Biosciences IncAnnounces Multi-Y - 富途牛牛
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies - GlobeNewswire
Cellectar Biosciences Earnings Notes - Trefis
MACD Signal: How Cellectar Biosciences Inc NV4 stock performs in easing cyclesRate Hike & Smart Money Movement Tracker - moha.gov.vn
Marginal Zone Lymphoma Treatment Pipeline Shows Strong Momentum as 50+ Pharma Companies in the Race | DelveInsight - The Globe and Mail
Cellectar Biosciences (CLRB) price target decreased by 44.05% to 47.94 - MSN
Can Cellectar Biosciences Inc. (NV4) stock retain market dominance2025 Top Decliners & Proven Capital Preservation Methods - Newser
Will Cellectar Biosciences Inc. (NV4) stock deliver compounding returnsWeekly Trend Summary & Advanced Swing Trade Entry Alerts - Newser
Will Cellectar Biosciences Inc. (NV4) stock maintain strong growthJuly 2025 Price Swings & Verified Trade Idea Suggestions - Newser
Is Cellectar Biosciences Inc. (NV4) stock supported by strong fundamentalsPrice Action & High Accuracy Trade Alerts - Newser
How reliable is Cellectar Biosciences Inc. (NV4) stock dividend growthDip Buying & Stock Portfolio Risk Management - Newser
Cellectar Biosciences (CLRB) Stock Analysis Report | Financials & Insights - Benzinga
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):